NCPA - National Center for Policy Analysis

Trans-Pacific Partnership Deal Undercuts Biologic Innovation

January 4, 2016

The United States and 11 other Pacific Rim countries recently signed the Trans-Pacific Partnership. Unfortunately, the final draft might not pass Congress, because of the deal's inadequate protection of intellectual property in biologic medicines.


Browse more articles on Health Issues